XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
6.83
+0.21 (3.17%)
Nov 22, 2024, 4:00 PM EST - Market closed
XBiotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | - | - | 4.01 | 18.39 | 43.98 | - | Upgrade
|
| Other Revenue | - | - | - | - | 0.02 | - | Upgrade
|
| Revenue | - | - | 4.01 | 18.39 | 44 | - | Upgrade
|
| Revenue Growth (YoY) | - | - | -78.20% | -58.19% | - | - | Upgrade
|
| Cost of Revenue | - | - | 0.65 | 5.82 | 34.55 | - | Upgrade
|
| Gross Profit | - | - | 3.36 | 12.57 | 9.45 | - | Upgrade
|
| Selling, General & Admin | 4.57 | 4.66 | 6.31 | 9.39 | 18.2 | 7.14 | Upgrade
|
| Research & Development | 37.74 | 32.85 | 31.54 | 28.27 | 9.53 | 24.09 | Upgrade
|
| Operating Expenses | 42.31 | 37.51 | 37.85 | 37.66 | 27.73 | 31.23 | Upgrade
|
| Operating Income | -42.31 | -37.51 | -34.49 | -25.08 | -18.28 | -31.23 | Upgrade
|
| Interest & Investment Income | 10.32 | 10.42 | 3.82 | 0.47 | 2.46 | 0.56 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.18 | 1.89 | -2.8 | -0.71 | 3.5 | -0.89 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 0.88 | -0.12 | -0.13 | -0.5 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -32.75 | -24.31 | -33.59 | -25.46 | -12.83 | -31.55 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 750 | Upgrade
|
| Pretax Income | -32.75 | -24.31 | -33.59 | -25.46 | -12.83 | 718.45 | Upgrade
|
| Income Tax Expense | -0.09 | 0.24 | -0.69 | -8.04 | -1.61 | 49.82 | Upgrade
|
| Net Income | -32.66 | -24.56 | -32.9 | -17.41 | -11.22 | 668.63 | Upgrade
|
| Net Income to Common | -32.66 | -24.56 | -32.9 | -17.41 | -11.22 | 668.63 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 31 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 31 | 46 | Upgrade
|
| Shares Change (YoY) | 0.06% | -0.00% | 1.32% | -2.53% | -33.45% | 29.37% | Upgrade
|
| EPS (Basic) | -1.07 | -0.81 | -1.08 | -0.58 | -0.36 | 17.17 | Upgrade
|
| EPS (Diluted) | -1.08 | -0.81 | -1.08 | -0.58 | -0.36 | 14.44 | Upgrade
|
| Free Cash Flow | -29.19 | -19.09 | -15.41 | 65.92 | -68.88 | -18.47 | Upgrade
|
| Free Cash Flow Per Share | -0.96 | -0.63 | -0.51 | 2.19 | -2.23 | -0.40 | Upgrade
|
| Gross Margin | - | - | 83.77% | 68.36% | 21.48% | - | Upgrade
|
| Operating Margin | - | - | -860.10% | -136.36% | -41.54% | - | Upgrade
|
| Profit Margin | - | - | -820.45% | -94.67% | -25.50% | - | Upgrade
|
| Free Cash Flow Margin | - | - | -384.26% | 358.38% | -156.55% | - | Upgrade
|
| EBITDA | -40.57 | -35.77 | -31.88 | -22.43 | -16.04 | -28.87 | Upgrade
|
| EBITDA Margin | - | - | - | -121.96% | -36.45% | - | Upgrade
|
| D&A For EBITDA | 1.74 | 1.74 | 2.61 | 2.65 | 2.24 | 2.36 | Upgrade
|
| EBIT | -42.31 | -37.51 | -34.49 | -25.08 | -18.28 | -31.23 | Upgrade
|
| EBIT Margin | - | - | - | -136.36% | -41.54% | - | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 6.93% | Upgrade
|
| Revenue as Reported | - | - | 4.01 | 18.39 | 44 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.